WHO MEDICINES STRATEGY 2004-2007 | 48EO 2.1TM/CAM <strong>int</strong>egrated in nationalhealth care systems whereappropriate by developing andimplementing national TM/CAMpolicies and programmesRationaleNational <strong>medicines</strong> policies are the basis for:defining the role of TM/CAM in national healthcare systems; ensuring that the necessaryregulatory and legal mechanisms are createdfor promoting and ma<strong>int</strong>aining good practice;assuring the authenticity, quality, safety andefficacy of TM/CAM products and therapies; andproviding equitable access to TM/CAM healthcare resources as well as information about them.In recognition of this, the WHA Resolution onTM urges Member States, where appropriate, toformulate and implement national policies andregulations on TM/CAM in support of proper useof traditional medicine, and its <strong>int</strong>egration <strong>int</strong>onational health care systems, depending on thecircumstances in their countries.ProgressOver the past four years, WHO has supportedcountries in their efforts to establish nationalpolicies on TM/CAM tailored to individual countryneeds. As a result, 39 countries now have anational policy on TM/CAM, compared with 25countries in 1999, and 46 countries are eitherestablishing or <strong>int</strong>end to establish a policy. Inaddition, WHO provided technical support inresponse to requests from Member States.published a global review document on the Legalstatus of traditional medicine and complementary/alternative medicine. 20 This review includesinformation and data from 123 countries and is<strong>int</strong>ended to help share their various experiencesamong Member States. In addition, in 2002-2003WHO conducted a global survey on nationalpolicy on TM/CAM, in order to assess the currentsituation and identify individual country needs fortechnical assistance from WHO.Challenges remainingIn many countries, efforts to establish a nationalpolicy and to ensure the regulation of TM/CAM medicine are hampered by the lack of:research and evidence-based information onTM/CAM; knowledge and understanding ofTM/CAM, which differs greatly from Westernmedicine in its philosophy and approaches; andeducation/training and qualification schemes forpractitioners. There is an urgent need for betterinformation sharing and for evidence-basedinformation to support Member States in efforts todevelop national policies and regulation to assurethe safety, efficacy, and quality of TM/CAM.In the Western Pacific Region, for example, theWHO Regional Office organized a series ofworkshops to support countries in developing andformulating their national policy on TM, issued adocument on the development of national policyon TM in 2000, and developed an action plan onTM in the Pacific Island States in 2001.In order to facilitate policy development, WHO
COMPONENTS OF THE STRATEGY | 49Figure 10:Development of National Policy onTM/CAMSource: Interim summary analysis of WHO globalsurvey on national policy on traditional medicineand complementary/alternative medicine, 2002-2003 Meeting the challenges 2004-2007Over the next four years WHO will:> based on the findings of the global survey onnational policy on TM/CAM in 2002-2003,analyse and review the current situationand identify the main difficulties faced byindividual Member States in formulatingthe national policy and regulation; provideguidance on the development of nationalpolicies on TM; and facilitate informationsharing among countries.> expand evidence-based information onquality, safety, and cost-effectiveness ofTM/CAM in order to support Member States,where appropriate, in their efforts to <strong>int</strong>egrateTM/CAM <strong>int</strong>o national health care systems.> provide <strong>int</strong>ensive medium-term technicalsupport to a selected number of <strong>int</strong>erestedcountries to help formulate a comprehensivenational policy/programme on TM/CAM andsupport its implementation.OUTCOME INDICATORS1999 2003 2007#REPORTING % TARGET#REPORTING % TARGETNo. of countries with national TM Policy C 25 na na 39/127 c 31% c 37%